GLP-1 receptor agonists (GLP-1 RAs), synthetic versions engineered for longer activity, have transformed the treatment of type 2 diabetes and obesity, with blockbuster drugs such as semaglutide and tirzepatide demonstrating unprecedented efficacy
Im on a CDK4/6 inhibitor like palbociclib or abemaciclib
Since it is applied directly as you take both, it penetrates all three layers of your skin quite easily
counsel on vomiting-related missed doses | | Levothyroxine | Cmax reduced ~16% | Recheck TSH at 6 to 8 weeks | | Digoxin | Tmax delayed 2.5 hours, Cmax reduced 17% | Check trough level at 5 to 7 days | | Metformin | Cmax reduced 9%, AUC unchanged | No adjustment | | Statins | Cmax reduced up to 38%, AUC unchanged | No adjustment | | ACE inhibitors/ARBs | Cmax reduced ~15%, AUC unchanged | No adjustment | | DPP-4 inhibitors | Pharmacologic redundancy | Discontinue DPP-4i | | SGLT2 inhibitors | Additive efficacy, no PK interaction | No adjustment | | DOACs | No data
:max_bytes(150000):strip_icc()/Simple-7-Day-GLP-1-Friendly-Meal-Plan-for-Beginners-Created-by-a-Dietitian-69f3d02b6c2c41928135df7f0c417552.jpg)
This interaction involves: Multiple hydrogen bond formations with ASP-111, VAL-175, and HIS-126 residues Salt bridge and pi-pi stacking interactions supporting binding stability Potential activation of cellular anti-aging pathways independent of muscle effects Antioxidant activity through SIRT1-mediated cellular protection mechanisms This dual mechanism suggests Syn-AKE may influence both immediate muscle activity and longer-term cellular aging processes